Philadelphia, PA: Protect Health Equity in Kidney Care

The Philadelphia Housing Authority invites you to join us for a special 2-day program on Critical Kidney Disease (CKD) as we address kidney failure and how it impacts the Black community. You will learn about CKD risk factors, screening, treatment options and critical information concerning The Kidney PATIENT Act.

You will have the opportunity to hear from and ask questions to several medical experts, community leaders and patients and walk away knowing how to better advocate for your health, diagnosis or a loved one. This is a free community event that’s open to all.

We’d like to extend a special thank you to our community partner, HEAL Collaborative.

Register now and share this with a loved one. We don’t want you to miss out! (Space is limited)

African Americans and CKD

While Blacks make up about 13% of the population, they account for 35% of the people with kidney failure, or end-stage renal disease (ESRD) and 33% of those on dialysis in the United States.

According to the CDC, 20% of the non-Hispanic Black population has CKD versus only 14% of non-Hispanic white adults. Poorly managed CKD often progresses to kidney failure, requiring individuals to undergo dialysis a few times weekly to stay alive.

Dialysis

Dialysis is a life-changing medical treatment, often consuming 10-12 hours per week at the dialysis clinic. Clearly, it is important to do everything possible to help CKD patients manage the enormous burden and challenges associated with dialysis.

Most individuals with CKD on dialysis depend upon the Medicare program to provide dialysis services and needed medications.

Due to the significant impact of CKD on the Black community, we are concerned about an upcoming policy change advanced by the Centers for Medicare and Medicaid Services (CMS) that will severely limit access to certain medications. We are educating and bringing awareness to the black community about CKD and this impending policy.

Learn More About The Kidney PATIENT Act

CMS changes to Medicare that will negatively impact patients who are on dialysis. People with kidney failure are prone to high levels of phosphate in their blood. Certain medications help to control and reduce the absorption of phosphate from the diet. New Medicare changes will deprive dialysis patients access to life-saving medications and increase costs for dialysis treatments.

The Kidney PATIENT Act 2023 | H.R. 5074

Registration is required

Tuesday, December 10

TIME: 10:00 AM- 12:00 PM ET

Wednesday, December 11

TIME: 10:00 AM- 12:00 PM ET

*Interactive Lunch & Learn

Sponsors:

Ardelyx

HEAL Collaborative